U.S., Nov. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07948928) titled 'EHR Alerts to Improve GLP-1 Medication and Continuous Glucose Monitor Prescribing in Primary Care' on Nov. 05.
Brief Summary: This randomized quality improvement study will evaluate whether pop-up alerts in the electronic health record (EHR) increase prescribing of glucagon-like peptide-1 receptor agonist (GLP-1 RA) medications and continuous glucose monitors (CGMs) for eligible patients with diabetes. The study will be conducted at nine Montefiore Medical Group primary care sites. Primary care providers will be randomly assigned to either receive the alerts or not receive them. The alerts will remind providers that a patient is eli...